Entries by medicalps

MagIA diagnostics announces that Mr. Philippe Jacon will be joining its Board

Mr. Jacon will be joining MagIA diagnostics’ board after a long career in the in-vitro diagnostics business. In his previous roles, Philippe JACON was the Executive Vice President, Emerging Markets, SVP Global Access at CEPHEID from 2013 to 2023. Previously, he was CEO of the Foundation of Innovative New Diagnostics (FIND), General Director of the […]

Une R&D collaborative école/entreprise adaptée aux projets de DM connectés

  Lors de la dernière édition de Medi’Nov, le directeur du transfert de technologie de l’école d’ingénieurs Grenoble INP – Esisar est venu faire le point sur le “Projet Industriel” dans le cadre des dispositifs médicaux : un programme de R&D collaborative qui favorise l’innovation au sein des start-up, TPE et PME.Par Karim Chibane, directeur […]

Première édition de la Biotech Community Day in the Alps à Medytec

  MEDICALPS & CIC Lyonnaise de Banque se sont associés pour organiser la première édition du Biotech Community Day in the Alps à Medytec, le 27 avril 2023. Cette journée fut l’opportunité de rassembler les acteurs de la biotechnologie de l’arc alpin lors d’une journée spéciale pour découvrir et redécouvrir la force de notre écosystème […]

,

BIOTEM implements new industrial unit dedicated to development and production of immunoassays

PRESS RELEASE – June, 20, 2022 – Apprieu (Grenoble) Leader in development of high-quality custom antibodies, BIOTEM is boosting expertise in immunoassays and increasing kit production capacity tenfold   Project partly supported by French government through France Relance economic initiative   Apprieu, near Grenoble, France, June 20, 2022 – BIOTEM, a hybrid Contract Research Organization […]

,

As SYNTHELIS and PEACCEL have signed a strategic partnership to offer their clients a one-stop shop combining Artificial Intelligence (AI) and Cell-Free lead expression for accelerated drug discovery

PRESS RELEASE – 12th April 2022- La Tronche   As of 12th April 2022, PEACCEL and SYNTHELIS combine their know-how and thus capitalize on their respective technologies in developing a joint offer, to respond to the needs of their customers and partners. This joint offer combines the innov’SAR industrial AI platform developed by PEACCEL and […]

,

Microlight 3D releases new range of resins for 3D microprinting

PRESS RELEASE – June 14th- Grenoble Eight new resins widen scope for mechanical meta-materials and life sciences researchers to 3D print, at micro scale, complex objects with novel properties Grenoble, France, June 14, 2022 – Microlight3D, a specialty manufacturer of high-resolution micro-scale 2D & 3D printing systems for industrial and scientific applications, today announces the […]

,

FDA Grants Breakthrough Device Designation to Remedee Labs for its groundbreaking endorphin stimulation solution for the management of Fibromyalgia

Paris – May 12, 2022 – On World Fibromyalgia Awareness Day (May 12), the French startup Remedee Labs is announcing that the FDA has granted Breakthrough Device Designation to its endorphin stimulator for fibromyalgia patients. The FDA’s Breakthrough Device program exists to accelerate market access for devices that improve care for people with severely debilitating […]

,

CEA: a key player in the field of Organ-on-Chip

On February 23rd  and 24st, 2022, the plenary meeting for the structuring of the OoC sector in France was held in Paris, organized by BioValley France (BVF), Institut Curie/IPGG and the CEA-IRIG (Interdisciplinary Research Institute of Grenoble) (http://irig.cea.fr). This event is a continuation of the digital directory of French experts in Organ-on-Chips (OoC) set up […]